Contec Research Development vs Tax Provision Analysis

300869 Stock

15.48 0.19 1.24%

Contec Medical financial indicator trend analysis is way more than just evaluating Contec Medical Systems prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Contec Medical Systems is a good investment. Please check the relationship between Contec Medical Research Development and its Tax Provision accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Contec Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Research Development vs Tax Provision

Research Development vs Tax Provision Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Contec Medical Systems Research Development account and Tax Provision. At this time, the significance of the direction appears to have very week relationship.

The correlation between Contec Medical's Research Development and Tax Provision is 0.25. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Tax Provision in the same time period over historical financial statements of Contec Medical Systems, assuming nothing else is changed. The correlation between historical values of Contec Medical's Research Development and Tax Provision is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Contec Medical Systems are associated (or correlated) with its Tax Provision. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Tax Provision has no effect on the direction of Research Development i.e., Contec Medical's Research Development and Tax Provision go up and down completely randomly.

Correlation Coefficient

0.25

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Research Development

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.

Most indicators from Contec Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Contec Medical Systems current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Contec Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Tax Provision is expected to grow to about 33.6 M, whereas Selling General Administrative is forecasted to decline to about 10 M.

	2021	2022	2023	2024 (projected)
Gross Profit	446.0M	338.1M	404.7M	317.7M
Total Revenue	908.7M	712.1M	734.0M	609.6M

Gross Profit Total Revenue

Contec Medical fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Other Liab	Net Tangible Assets	Deferred Long Term Liab
Total Assets		0.51	0.86	0.99	0.84	0.61	0.98	-0.02	0.84	0.86	0.59	0.83	0.93	0.78	0.63	0.84	0.92	0.6	0.92	0.97	0.98	0.93	0.71	0.7	0.93	-0.83
Other Current Liab	0.51		0.55	0.53	0.35	-0.11	0.48	0.59	0.63	0.52	0.49	0.26	0.41	0.58	0.51	0.24	0.54	0.35	0.7	0.46	0.47	0.29	0.35	0.2	0.52	-0.32
Total Current Liabilities	0.86	0.55		0.82	0.82	0.35	0.82	0.28	0.91	0.97	0.88	0.5	0.62	0.91	0.53	0.54	0.9	0.85	0.77	0.88	0.76	0.71	0.62	0.47	0.87	-0.68
Total Stockholder Equity	0.99	0.53	0.82		0.79	0.56	0.99	-0.01	0.8	0.85	0.58	0.78	0.93	0.73	0.68	0.78	0.91	0.51	0.93	0.92	0.96	0.89	0.76	0.66	0.93	-0.88
Property Plant And Equipment Net	0.84	0.35	0.82	0.79		0.65	0.84	0.0	0.71	0.81	0.53	0.71	0.75	0.62	0.3	0.73	0.91	0.59	0.77	0.88	0.81	0.79	0.43	0.73	0.9	-0.55
Net Debt	0.61	-0.11	0.35	0.56	0.65		0.64	-0.65	0.17	0.33	-0.03	0.8	0.71	0.12	0.09	0.8	0.51	0.14	0.54	0.65	0.67	0.79	0.11	0.54	0.46	-0.31
Retained Earnings	0.98	0.48	0.82	0.99	0.84	0.64		-0.03	0.76	0.84	0.56	0.81	0.93	0.7	0.57	0.81	0.9	0.49	0.93	0.93	0.96	0.9	0.66	0.66	0.93	-0.82
Accounts Payable	-0.02	0.59	0.28	-0.01	0.0	-0.65	-0.03		0.36	0.27	0.51	-0.38	-0.23	0.39	0.03	-0.36	0.07	0.26	0.05	-0.04	-0.13	-0.34	0.07	-0.21	0.13	-0.01
Cash	0.84	0.63	0.91	0.8	0.71	0.17	0.76	0.36		0.85	0.76	0.56	0.66	0.96	0.63	0.59	0.82	0.86	0.73	0.86	0.78	0.69	0.72	0.59	0.83	-0.74
Non Current Assets Total	0.86	0.52	0.97	0.85	0.81	0.33	0.84	0.27	0.85		0.9	0.44	0.62	0.85	0.56	0.47	0.91	0.71	0.79	0.83	0.74	0.67	0.67	0.42	0.91	-0.75
Non Currrent Assets Other	0.59	0.49	0.88	0.58	0.53	-0.03	0.56	0.51	0.76	0.9		0.06	0.25	0.84	0.47	0.1	0.68	0.74	0.52	0.57	0.42	0.34	0.57	0.09	0.67	-0.58
Other Assets	0.83	0.26	0.5	0.78	0.71	0.8	0.81	-0.38	0.56	0.44	0.06		0.94	0.45	0.41	1.0	0.67	0.36	0.74	0.85	0.92	0.94	0.43	0.84	0.66	-0.58
Cash And Short Term Investments	0.93	0.41	0.62	0.93	0.75	0.71	0.93	-0.23	0.66	0.62	0.25	0.94		0.54	0.57	0.94	0.79	0.35	0.87	0.88	0.98	0.94	0.62	0.79	0.81	-0.76
Net Receivables	0.78	0.58	0.91	0.73	0.62	0.12	0.7	0.39	0.96	0.85	0.84	0.45	0.54		0.59	0.48	0.74	0.89	0.65	0.81	0.69	0.62	0.65	0.44	0.74	-0.7
Common Stock Shares Outstanding	0.63	0.51	0.53	0.68	0.3	0.09	0.57	0.03	0.63	0.56	0.47	0.41	0.57	0.59		0.4	0.65	0.4	0.59	0.54	0.62	0.56	0.88	0.46	0.62	-0.79
Non Current Liabilities Total	0.84	0.24	0.54	0.78	0.73	0.8	0.81	-0.36	0.59	0.47	0.1	1.0	0.94	0.48	0.4		0.68	0.42	0.73	0.87	0.92	0.94	0.44	0.84	0.67	-0.59
Inventory	0.92	0.54	0.9	0.91	0.91	0.51	0.9	0.07	0.82	0.91	0.68	0.67	0.79	0.74	0.65	0.68		0.62	0.87	0.9	0.87	0.82	0.7	0.69	0.98	-0.75
Other Current Assets	0.6	0.35	0.85	0.51	0.59	0.14	0.49	0.26	0.86	0.71	0.74	0.36	0.35	0.89	0.4	0.42	0.62		0.42	0.72	0.53	0.54	0.48	0.39	0.57	-0.44
Other Stockholder Equity	0.92	0.7	0.77	0.93	0.77	0.54	0.93	0.05	0.73	0.79	0.52	0.74	0.87	0.65	0.59	0.73	0.87	0.42		0.86	0.9	0.82	0.56	0.56	0.87	-0.68
Total Liab	0.97	0.46	0.88	0.92	0.88	0.65	0.93	-0.04	0.86	0.83	0.57	0.85	0.88	0.81	0.54	0.87	0.9	0.72	0.86		0.96	0.94	0.6	0.72	0.88	-0.73
Total Current Assets	0.98	0.47	0.76	0.96	0.81	0.67	0.96	-0.13	0.78	0.74	0.42	0.92	0.98	0.69	0.62	0.92	0.87	0.53	0.9	0.96		0.96	0.67	0.78	0.88	-0.8
Intangible Assets	0.93	0.29	0.71	0.89	0.79	0.79	0.9	-0.34	0.69	0.67	0.34	0.94	0.94	0.62	0.56	0.94	0.82	0.54	0.82	0.94	0.96		0.59	0.77	0.79	-0.72
Common Stock	0.71	0.35	0.62	0.76	0.43	0.11	0.66	0.07	0.72	0.67	0.57	0.43	0.62	0.65	0.88	0.44	0.7	0.48	0.56	0.6	0.67	0.59		0.52	0.74	-0.92
Other Liab	0.7	0.2	0.47	0.66	0.73	0.54	0.66	-0.21	0.59	0.42	0.09	0.84	0.79	0.44	0.46	0.84	0.69	0.39	0.56	0.72	0.78	0.77	0.52		0.71	-0.58
Net Tangible Assets	0.93	0.52	0.87	0.93	0.9	0.46	0.93	0.13	0.83	0.91	0.67	0.66	0.81	0.74	0.62	0.67	0.98	0.57	0.87	0.88	0.88	0.79	0.74	0.71		-0.82
Deferred Long Term Liab	-0.83	-0.32	-0.68	-0.88	-0.55	-0.31	-0.82	-0.01	-0.74	-0.75	-0.58	-0.58	-0.76	-0.7	-0.79	-0.59	-0.75	-0.44	-0.68	-0.73	-0.8	-0.72	-0.92	-0.58	-0.82

Click cells to compare fundamentals

Contec Medical Account Relationship Matchups

Contec Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	679.2M	2.1B	2.8B	3.7B	3.2B	3.4B
Other Current Liab	12.6M	115.1M	60.9M	76.6M	51.7M	60.0M
Total Current Liabilities	81.2M	514.9M	955.6M	1.1B	459.9M	364.1M
Total Stockholder Equity	583.2M	1.6B	1.8B	1.9B	2.0B	2.1B
Property Plant And Equipment Net	72.3M	151.1M	226.1M	275.1M	291.2M	160.0M
Net Debt	(165.4M)	(546.1M)	180.3M	183.3M	576.7M	605.5M
Retained Earnings	166.6M	718.1M	936.0M	992.2M	1.1B	1.1B
Accounts Payable	33.1M	93.4M	47.6M	54.3M	17.8M	16.9M
Cash	184.3M	814.1M	624.0M	1.4B	470.5M	422.7M
Non Current Assets Total	294.1M	830.6M	1.4B	1.2B	738.7M	526.7M
Non Currrent Assets Other	206.5M	640.5M	1.2B	820.9M	2.0	1.9
Cash And Short Term Investments	184.3M	814.1M	624.0M	1.4B	2.0B	2.1B
Net Receivables	63.9M	117.3M	115.4M	201.2M	47.0M	75.7M
Common Stock Shares Outstanding	366.9M	364.9M	401.8M	408.8M	414.4M	364.4M
Liabilities And Stockholders Equity	679.2M	2.1B	2.8B	3.7B	3.2B	3.4B
Non Current Liabilities Total	14.8M	14.1M	13.3M	691.9M	707.2M	742.5M
Inventory	128.1M	284.4M	418.7M	430.2M	463.2M	245.8M
Other Current Assets	8.8M	51.4M	194.1M	487.7M	8.6M	8.2M
Other Stockholder Equity	41.8M	48.7M	11.8M	344.8M	396.5M	416.4M
Total Liab	96.0M	529.0M	969.0M	1.8B	1.2B	1.2B
Total Current Assets	385.1M	1.3B	1.4B	2.6B	2.5B	2.6B
Intangible Assets	15.2M	13.1M	33.6M	57.5M	54.7M	57.5M
Other Liab	14.8M	14.1M	10.6M	20.9M	24.1M	15.4M
Net Tangible Assets	568.0M	1.6B	1.8B	1.9B	2.2B	1.1B
Property Plant Equipment	72.3M	151.1M	226.1M	275.1M	316.4M	332.2M
Net Invested Capital	602.1M	1.8B	2.6B	3.5B	3.1B	2.0B
Net Working Capital	304.0M	752.3M	396.5M	1.4B	2.0B	2.1B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Other Information on Investing in Contec Stock

Balance Sheet is a snapshot of the financial position of Contec Medical Systems at a specified time, usually calculated after every quarter, six months, or one year. Contec Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Contec Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Contec currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Contec Research Development vs Tax Provision Analysis

Research Development vs Tax Provision

Research Development vs Tax Provision Correlation Analysis

Correlation Coefficient

Research Development

Tax Provision

Contec Medical fundamental ratios Correlations

Contec Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Contec Medical fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Contec Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Liabilities Total	+ 1.0	Other Assets
Total Stockholder Equity	+ 0.99	Total Assets
Retained Earnings	+ 0.99	Total Stockholder Equity
Retained Earnings	+ 0.98	Total Assets
Total Current Assets	+ 0.98	Total Assets
Total Current Assets	+ 0.98	Cash And Short Term Investments

Deferred Long Term Liab	- 0.92	Common Stock
Deferred Long Term Liab	- 0.88	Total Stockholder Equity
Deferred Long Term Liab	- 0.83	Total Assets
Deferred Long Term Liab	- 0.82	Net Tangible Assets
Deferred Long Term Liab	- 0.82	Retained Earnings
Deferred Long Term Liab	- 0.8	Total Current Assets